• KAFM
  • Contact us
  • E-Submission
ABOUT
ARTICLE CATEGORY
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

1
results for

"Pharmacovigilance"

Filter

Article category

Keywords

Publication year

Authors

"Pharmacovigilance"

Review Article
Pharmacovigilance and Its Importance for Primary Health Care Professionals
Asma A’tiyah Abdul Hamid, Rashidah Rahim, Shyh Poh Teo
Korean J Fam Med 2022;43(5):290-295.   Published online September 20, 2022
DOI: https://doi.org/10.4082/kjfm.21.0193
Pharmacovigilance is used to detect, assess, understand, and prevent the adverse effects of medications. The need for safety monitoring has evolved around unfortunate incidents in history, with deaths caused by anesthesia and congenital malformations from thalidomide use. Reports from adverse drug reactions (ADRs) are stored in a global database and can be used to evaluate the associations between various medications and associated ADRs. Clinicians play an important role in the recognition and reporting of ADRs to national pharmacovigilance centers (NPCs). The purpose of NPCs is to make the clinicians understand their functions, including the monitoring, investigation, and assessment of ADR reports, along with periodical benefit-risk assessments of medications via multiple sources. A case study on NPCs and the types of safety issues evaluated by them are provided to illustrate their role in medicine safety surveillance. ADR monitoring was also combined with vaccine safety surveillance approaches. Overall, this study will provide insights to clinicians on the importance of pharmacovigilance in maintaining patient safety with the proper use of medications.

Citations

Citations to this article as recorded by  
  • Teaching approaches to delivering pharmacy law content to pre-registration pharmacy students: a global systematic scoping review
    Helen Ibrahim, Bandana Saini, Jessica Pace
    Currents in Pharmacy Teaching and Learning.2026; 18(1): 102507.     CrossRef
  • Analysis of literature-derived duplicate records in the FDA Adverse Event Reporting System (FAERS) database
    Weiru Han, Robert Morris, Kun Bu, Tianrui Zhu, Hong Huang, Feng Cheng
    Canadian Journal of Physiology and Pharmacology.2025; 103(2): 56.     CrossRef
  • Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review
    Su Golder, Dongfang Xu, Karen O’Connor, Yunwen Wang, Mahak Batra, Graciela Gonzalez Hernandez
    Drug Safety.2025; 48(4): 321.     CrossRef
  • Patient Experience Regarding Medication-Related Information Received in a Rural Private Polyclinic Setting in Vietnam
    Quang Loc Duyen Vo, Minh Trung Nguyen, Thi Ngoc Yen Dang, Thi Hong Dung Quach, Huynh Kim Ngoc Truong, Rebecca Susan Dewey, Thi Thu Tran, Van De Tran
    Journal of Patient Experience.2025;[Epub]     CrossRef
  • Interações Fármaco-fármaco em Prescrições de Pacientes em Unidade de Terapia Intensiva Adulto em Hospital Público de Montes Claros
    Anna Lívia Lima, Kelly Cristiane Lopes, Esther Alves Marinho , Flávio Júnior Figueredo , Cecília Paiva Duarte , Viviane de Oliveira Vasconcelos, Izabella Mendes Lima , Thiago Santos Monção, Guilherme Henrique Azevedo dos Reis , Yves André Rodrigues Gomes
    Revista de Gestão e Secretariado.2025; 16(2): e4715.     CrossRef
  • A critical comparison of pharmacovigilance reporting forms in six countries with the WHO-UMC recommendations (form of the form)
    Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi
    Journal of Basic and Clinical Physiology and Pharmacology.2025; 36(4): 285.     CrossRef
  • Glucocorticoid withdrawal syndrome: Disproportionality analysis of cases using VigiBase data
    Lütfi Mangal, Burcu Eda Arda, Hande Sipahi
    DARU Journal of Pharmaceutical Sciences.2025;[Epub]     CrossRef
  • Enhancing Public Health with Pharmacovigilance: Tools, Strategies, and Impacts
    Sujitha Pandian, Yashvanthan Vinjmur Ragavan, Angeline Grace Pandian, Ajith Kumar Kumaraguru, Kiran Kartheep Subramanian
    Biomedical and Pharmacology Journal.2025; 18(2): 1147.     CrossRef
  • Artificial Intelligence in Pharmacovigilance
    Dinesh Kumar, Amandeep Kaur, Shruti, Davender Kaur
    Current Computer Science.2025;[Epub]     CrossRef
  • Excipients in pharmaceuticals: mechanisms of hypersensitivity and the role of global pharmacovigilance
    Ruba Malkawi, Lora Altahrawi
    Saudi Pharmaceutical Journal.2025;[Epub]     CrossRef
  • Exploring pharmacovigilance awareness and attitudes among healthcare practitioners in Iraq: insights from a survey-based study
    Hussein Abdulmohsin Dabis, Ali Talib Hameed
    Jurnal Ners.2025; 20(1): 3.     CrossRef
  • A PHARMACOVIGILANCE STUDY TO ASSESS THE EFFECT OF ADVERSE DRUG REACTION ON PEDIATRIC HEALTH
    ARULRAJA S, THILIP KUMAR GNANADURAI, SUBBULAKSHMI RAMASAMY
    Asian Journal of Pharmaceutical and Clinical Research.2025; : 87.     CrossRef
  • Association between DPP4 inhibitor use and risk of skin cancer in type 2 diabetes: A real-world cohort study
    Zaryab Alam, Kevin T. Nguyen, Hamza Malick, Kyle C. Lauck, Stanislav N. Tolkachjov
    Journal of the American Academy of Dermatology.2025;[Epub]     CrossRef
  • Safety of COVID-19 Vaccination During Pregnancy and Lactation: A VigiBase Analysis
    Dayeon Kang, Ahhyung Choi, Suneun Park, Seung-Ah Choe, Ju-Young Shin
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry
    Seema Yadav, Abhishek Singh, Rishika Singhal, Jagat Pal Yadav
    Intelligent Pharmacy.2024; 2(3): 367.     CrossRef
  • Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
    Robert Morris, Rahinatu Ali, Feng Cheng
    Current Drug Targets.2024; 25(7): 454.     CrossRef
  • Drug-Related Glomerular Phenotypes: A Global Pharmacovigilance Perspective
    Alexandre Baptista, Ana M. Macedo, Ana Marreiros, André Coelho, Mark A. Perazella
    Journal of Clinical Medicine.2024; 13(16): 4869.     CrossRef
  • Postmarketing Surveillance: Review of Open Sources of Drug Safety Data
    E. V. Shubnikova
    Safety and Risk of Pharmacotherapy.2024; 12(3): 309.     CrossRef
  • Exploring the community pharmacist’s knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study
    Javedh Shareef, Sathvik Belagodu Sridhar, Mullaicharam Bhupathyraaj, Atiqulla Shariff, Sabin Thomas
    Therapeutic Advances in Drug Safety.2024;[Epub]     CrossRef
  • Pharmacovigilance: A Comprehensive Review of Drug Safety Monitoring Practices
    Aniket Anil Pawar, Aftab Imtiyaz Patel, Suhani Balu Jadhav, Harshavardhan T. Suryawanshi, Suhani Balu Jadhav
    International Journal of Advanced Research in Science, Communication and Technology.2024; : 314.     CrossRef
  • Explicit potentially inappropriate medications criteria for older population in Asian countries: A systematic review
    Chee Tao Chang, Siew Li Teoh, Philip Rajan, Shaun Wen Huey Lee
    Research in Social and Administrative Pharmacy.2023; 19(8): 1146.     CrossRef
  • A Real-World Data Driven Pharmacovigilance Investigation on Drug-Induced Arrhythmia Using KAERS DB, a Korean Nationwide Adverse Drug Reporting System
    Chaerin Go, Semi Kim, Yujin Kim, Yongjun Sunwoo, Sae Hyun Eom, Jiseong Yun, Sooyoung Shin, Yeo Jin Choi
    Pharmaceuticals.2023; 16(11): 1612.     CrossRef
  • 6,416 View
  • 153 Download
  • 13 Web of Science
  • 22 Crossref
TOP